Rage receptor and its soluble isoforms in diabetes mellitus complications : O receptor rage e suas isoformas solúveis nas complicações do diabetes mellitus

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 49, Issue 2, 2013, Pages 97-108

  Oliveira, Mauren Isfer Anghebem ^a   De Souza, Emanuel Maltempi ^b   Pedrosa, Fábio De Oliveira ^b   Réa, Rosângela Roginski ^c   Alves, Alexessander Da Silva Couto ^d   Geraldo Picheth, ^e   Fabiane Gomes de Moraes Rego, ^e  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Doctor in Biochemistry and Molecular Biology by UFPR   (Brazil)

^c UFPR Clinical hospital   (Brazil)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Doctor in Biochemistry and Molecular Biology by UFPR   (Brazil)

Author keywords

Diabetes complications; RAGE isoforms; RAGE receptor; RAGE soluble isoforms

Indexed keywords

EID: 84879774753     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442013000200004     Document Type: Review

References (81)

1. Ada. American Diabetes Association. Standards Of Medical Care In Diabetes -2012. Diabetes Care, V. 35, P. S11-63, 2012.
2. Bierhaus, A.; Nawroth, P. P. Multiple Levels Of Regulation Determine The Role Of The Receptor For Age (Rage) As Common Soil In Inflammation, Immune Responses And Diabetes Mellitus And Its Complications. Diabetologia, V. 52, P. 2251-63, 2009.
3. Bos, D. C.; De Ranitz-Greven, W. L.; De Valk, H. W. Advanced Glycation End Products, Measured As Skin Autofluorescence And Diabetes Complications: A Systematic Review. Diabetes Technol Ther, V. 13, P. 773-9, 2011.
4. Boso, M. Et Al. Alterations Of Circulating Endogenous Secretory Rage And S100A9 Levels Indicating Dysfunction Of The Age-Rage Axis In Autism. Neurosci Lett, V. 410, P. 169-73, 2006. (Pubitemid 44750339)
5. Brown, L. F.; Fraser, C. G. Assay Validation And Biological Variation Of Serum Receptor For Advanced Glycation End-Products. Ann Clin Biochem, V. 45, P. 518-9, 2008.
6. Brownlee, M. Biochemistry And Molecular Cell Biology Of Diabetic Complications. Nature, V. 414, P. 813-20, 2001. (Pubitemid 34000785)
7. Brownlee, M. The Pathobiology Of Diabetic Complications: A Unifying Mechanism. Diabetes, V. 54, P. 1615-25, 2005. (Pubitemid 40770750)
8. Buckley, S. T.; Ehrhardt, C. The Receptor For Advanced Glycation End Products (Rage) And The Lung. J Biomed Biotechnol, V. 2010, P. 917108, 2010.
9. Ceriello, A. Hypothesis: The Metabolic Memory, The New Challenge Of Diabetes. Diabetes Res Clin Pract, V. 86, P. S2-6, 2009.
10. Choi, K. M. Et Al. Association Between Endogenous Secretory Rage, Inflammatory Markers And Arterial Stiffness. Int J Cardiol, V. 132, P. 96-101, 2009.
11. Colhoun, H. M. Et Al. Total Soluble And Endogenous Secretory Receptor For Advanced Glycation End Products As Predictive Biomarkers Of Coronary Heart Disease Risk In Patients With Type 2 Diabetes: An Analysis From The Cards Trial. Diabetes, V. 60, P. 2379-85, 2011.
12. Creagh-Brown, B. C. Et Al. The Rage Axis In Systemic Inflammation, Acute Lung Injury And Myocardial Dysfunction: An Important Therapeutic Target? Intensive Care Med, V. 36, P. 1644-56, 2010.
13. Dailey, G. Overall Mortality In Diabetes Mellitus: Where Do We Stand Today? Diabetes Technol Ther, V. 13, P. S65-74, 2011.
14. Datasus. Indicadores E Dados Basicos. Idb. Brasil. 2009. DisponíVel Em: . Acesso Em: 7 Jan. 2011.
15. Dettoraki, A.; Gil, A. P.; Spiliotis, B. E. Association Between Serum Levels Of The Soluble Receptor (Srage) For Advanced Glycation Endproducts (Ages) And Their Receptor (Rage) In Peripheral Blood Mononuclear Cells Of Children With Type 1 Diabetes Mellitus. J Pediatr Endocrinol Metab, V. 22, P. 895-904, 2009.
16. Falcone, C. Et Al. Plasma Levels Of Soluble Receptor For Advanced Glycation End Products And Coronary Artery Disease In Nondiabetic Men. Arterioscler Thromb Vasc Biol, V. 25, P. 1032-7, 2005.
17. Fleming, T. H. Et Al. Reactive Metabolites And Age/Rage-Mediated Cellular Dysfunction Affect The Aging Process - A Mini-Review. Gerontology, V. 57, P. 435-43, 2011.
18. Gefter, J. V. Et Al. Comparison Of Distinct Protein Isoforms Of The Receptor For Advanced Glycation End-Products Expressed In Murine Tissues And Cell Lines. Cell Tissue Res, V. 337, P.79-89, 2009.
19. Geroldi, D. Et Al. High Levels Of Soluble Receptor For Advanced Glycation End Products May Be A Marker Of Extreme Longevity In Humans. J Am Geriatr Soc, V. 54, P. 1149-50, 2006. (Pubitemid 43992560)
20. Giannini, C. Et Al. The Possible Role Of Esrage And Srage In The Natural History Of Diabetic Nephropathy In Childhood. Pediatr Nephrol, V. 27, P. 269-75, 2012.
21. Gu, H. Et Al. Gly82Ser Polymorphism Of The Receptor For Advanced Glycation End Products Is Associated With An Increased Risk Of Gastric Cancer In A Chinese Population. Clin Cancer Res, V. 14, P. 3627-32, 2008.
22. Hancock, D. B. Et Al. Meta-Analyses Of Genome-Wide Association Studies Identify Multiple Loci Associated With Pulmonary Function. Nat Genet, V. 42, P. 45-52, 2010.
23. Harja, E. Et Al. Vascular And Inflammatory Stresses Mediate Atherosclerosis Via Rage And Its Ligands In Apoe-/-Mice. J Clin Invest, V. 118, P. 183-94, 2008.
24. Hartog, J. W. Et Al. Advanced Glycation End-Products (Ages) And Heart Failure: Pathophysiology And Clinical Implications. Eur J Heart Fail, V. 9, P. 1146-55, 2007. (Pubitemid 350138497)
25. Hudson, B. I. Et Al. Effects Of Novel Polymorphisms In The Rage Gene On Transcriptional Regulation And Their Association With Diabetic Retinopathy. Diabetes, V. 50, P. 1505-11, 2001. (Pubitemid 32500186)
26. Hudson, B. I. Et Al. Interaction Of The Rage Cytoplasmic Domain With Diaphanous-1 Is Required For Ligand-Stimulated Cellular Migration Through Activation Of Rac1 And Cdc42. J Biol Chem, V. 283, P. 34457-68, 2008A.
27. Hudson, B. I. Et Al. Identification, Classification, And Expression Of Rage Gene Splice Variants. Faseb J, V. 22, P. 1572-80, 2008B. (Pubitemid 351656797)
28. Hung, L. F. Et Al. Advanced Glycation End Products Induce T Cell Apoptosis: Involvement Of Oxidative Stress, Caspase And The Mitochondrial Pathway. Mech Ageing Dev, V. 131, P. 682-91, 2010.
29. Iacobini, C. Et Al. Advanced Lipoxidation End-Products Mediate Lipidinduced Glomerular Injury: Role Of Receptor-Mediated Mechanisms. J Pathol, V. 218, P. 360-9, 2009.
30. Jax, T. W. Metabolic Memory: A Vascular Perspective. Cardiovasc Diabetol, V. 9, P. 51, 2010.
31. Jeong, I. K.; King, G. L. New Perspectives On Diabetic Vascular Complications: The Loss Of Endogenous Protective Factors Induced By Hyperglycemia. Diabetes Metab J, V. 35, P. 8-11, 2011.
32. Jiao, L. Et Al. Evidence That Serum Levels Of The Soluble Receptor For Advanced Glycation End Products Are Inversely Associated With Pancreatic Cancer Risk: A Prospective Study. Cancer Res, V. 71, P. 3582-9, 2011.
33. Kalea, A. Z.; Schmidt, A. M.; Hudson, B. I. Rage: A Novel Biological And Genetic Marker For Vascular Disease. Clin Sci (Lond), V. 116, P. 621-37, 2009.
34. Kalea, A. Z.; Schmidt, A. M.; Hudson, B. I. Alternative Splicing Of Rage: Roles In Biology And Disease. Front Biosci, V. 17, P. 2756-70, 2011.
35. Kalousová, M. Et Al. Genetic Predisposition To Advanced Glycation End Products Toxicity Is Related To Prognosis Of Chronic Hemodialysis Patients. Kidney Blood Press Res, V. 33, P. 30-6, 2010.
36. Katakami, N. Et Al. Serum Endogenous Secretory Rage Level Is An Independent Risk Factor For The Progression Of Carotid Atherosclerosis In Type 1 Diabetes. Atherosclerosis, V. 204, P. 288-92, 2009.
37. Kislinger, T. Et Al. N(Epsilon)-(Carboxymethyl)Lysine Adducts Of Proteins Are Ligands For Receptor For Advanced Glycation End Products That Activate Cell Signaling Pathways And Modulate Gene Expression. J Biol Chem, V.274, P. 31740-9, 1999.
38. Krechler, T. Et Al. Soluble Receptor For Advanced Glycation End-Products (Srage) And Polymorphisms Of Rage And Glyoxalase I Genes In Patients With Pancreas Cancer. Clin Biochem, V. 43, P. 882-6, 2010.
39. Kojro, E.; Postina, R. Regulated Proteolysis Of Rage And Abetapp As Possible Link Between Type 2 Diabetes Mellitus And Alzheimers Disease. J Alzheimers Dis, V. 16, P. 865-78, 2009.
40. Koyama, H. Et Al. Plasma Level Of Endogenous Secretory Rage Is Associated With Components Of The Metabolic Syndrome And Atherosclerosis. Arterioscler Thromb Vasc Biol, V. 25, P. 2587-93, 2005. (Pubitemid 43732283)
41. Lanati, N. Et Al. Soluble Rage-Modulating Drugs: State-Of-The-Art And Future Perspectives For Targeting Vascular Inflammation. Curr Vasc Pharmacol, V. 8, P. 86-92, 2010.
42. Li, K. Et Al. A Functional P.82G>S Polymorphism In The Rage Gene Is Associated With Multiple Sclerosis In The Chinese Population. Mult Scler, V. 17, P. 914-21, 2011.
43. Lindsey, J. B. Et Al. Receptor For Advanced Glycation End-Products (Rage) And Soluble Rage (Srage): Cardiovascular Implications. Diab Vasc Dis Res, V. 6, P. 7-14, 2009.
44. Lu, W.; Feng, B. The -374A Allele Of The Rage Gene As A Potential Protective Factor For Vascular Complications In Type 2 Diabetes: A Meta-Analysis. Tohoku J Exp Med, V. 220, P. 291-7, 2010.
45. Mccarthy, M. I. Genomics, Type 2 Diabetes, And Obesity. N Engl J Med, V. 363, P. 2339-50, 2010.
46. Malherbe, P. Et Al. Cdna Cloning Of A Novel Secreted Isoform Of The Human Receptor For Advanced Glycation End Products And Characterization Of Cells Co-Expressing Cell-Surface Scavenger Receptors And Swedish Mutant Amyloid Precursor Protein. Brain Res Mol Brain Res, V. 71, P. 159-70, 1999. (Pubitemid 29492960)
47. Marcovecchio, M. L.; Lucantoni, M.; Chiarelli, F. Role Of Chronic And Acute Hyperglycemia In The Development Of Diabetes Complications. Diabetes Technol Ther, V. 13, P. 389-94, 2011.
48. Miyazawa, T. Et Al. Lipid Glycation And Protein Glycation In Diabetes And Atherosclerosis. Amino Acids, V. 42, P. 1163-70, 2012.
49. Nakamura, K. Et Al. Elevation Of Soluble Form Of Receptor For Advanced Glycation End Products (Srage) In Diabetic Subjects With Coronary Artery Disease. Diabetes Metab Res Rev, V. 23, P. 368-71, 2007A. (Pubitemid 47091239)
50. Nakamura, K. Et Al. Serum Levels Of Srage, The Soluble Form Of Receptor For Advanced Glycation End Products, Are Associated With Inflammatory Markers In Patients With Type 2 Diabetes. Mol Med, V. 13, P. 185-9, 2007B.
51. Nakamura, K. Et Al. Serum Levels Of Soluble Form Of Receptor For Advanced Glycation End Products (Srage) Are Positively Associated With Circulating Ages And Soluble Form Of Vcam-1 In Patients With Type 2 Diabetes. Microvasc Res, V. 76, P. 52-6, 2008.
52. Neeper, M. Et Al. Cloning And Expression Of A Cell Surface Receptor For Advanced Glycosylation End Products Of Proteins. J Biol Chem, V. 267, P. 4998-5004, 1992.
53. Nishizawa, Y.; Koyama, H. Endogenous Secretory Receptor For Advanced Glycation End-Products And Cardiovascular Disease In End-Stage Renal Disease. J Ren Nutr, V. 18, P. 76-82, 2008. (Pubitemid 350251832)
54. Ohe, K. Et Al. Regulation Of Alternative Splicing Of The Receptor For Advanced Glycation Endproducts (Rage) Through G-Rich Cis-Elements And Heterogeneous Nuclear Ribonucleoprotein H. J Biochem, V. 147, P. 651-9, 2010.
55. Picheth, G. Et Al. The -374A Allele Of The Receptor For Advanced Glycation End Products (Rage) Gene Promoter Is A Protective Factor Against Cardiovascular Lesions In Type 2 Diabetes Mellitus Patients. Clin Chem Lab Med, V. 45, P. 1268-72, 2007A. (Pubitemid 47557065)
56. Picheth, G. Et Al. The -429 T>C Polymorphism Of The Receptor For Advanced Glycation End Products (Rage) Is Associated With Type 1 Diabetes In A Brazilian Population. Clin Chim Acta, V. 383, P. 163-4, 2007B.
57. Rains, J. L.; Jain, S. K. Oxidative Stress, Insulin Signaling, And Diabetes. Free Radic Biol Med, V. 50, P. 567-75, 2011.
58. Ramasamy, R.; Yan, S. F.; Schmidt, A. M. Advanced Glycation Endproducts: From Precursors To Rage: Round And Round We Go. Amino Acids, V. 42, P. 1151-61, 2012.
59. Raposeiras-Roubín, S. Et Al. Soluble Receptor Of Advanced Glycation End Products Levels Are Related To Ischaemic Aetiology And Extent Of Coronary Disease In Chronic Heart Failure Patients, Independent Of Advanced Glycation End Products Levels: New Roles For Soluble Rage. Eur J Heart Fail, V. 12, P. 1092-100, 2010.
60. Raucci, A. Et Al. A Soluble Form Of The Receptor For Advanced Glycation Endproducts (Rage) Is Produced By Proteolytic Cleavage Of The Membranebound Form By The Sheddase A Disintegrin And Metalloprotease 10 (Adam10). Faseb J, V. 22, P. 3716-27, 2008.
61. Santilli, F. Et Al. Soluble Forms Of Rage In Human Diseases: Clinical And Therapeutical Implications. Curr Med Chem, V. 16, P. 940-52, 2009.
62. Schlueter, C. Et Al. Tissue-Specific Expression Patterns Of The Rage Receptor And Its Soluble Forms-A Result Of Regulated Alternative Splicing? Biochim Biophys Acta, V. 1630, P. 1-6, 2003.
63. Semba, R. D. Et Al. Elevated Serum Advanced Glycation End Products And Their Circulating Receptors Are Associated With Anaemia In Older Communitydwelling Women. Age Ageing, V. 38, P. 283-9, 2009A.
64. Semba, R. D. Et Al. Advanced Glycation End Products And Their Circulating Receptors And Level Of Kidney Function In Older Community-Dwelling Women. Am J Kidney Dis, V. 53, P. 51-8, 2009B.
65. Sourris, K. C.; Forbes, J. M. Interactions Between Advanced Glycation End-Products (Age) And Their Receptors In The Development And Progression Of Diabetic Nephropathy -Are These Receptors Valid Therapeutic Targets. Curr Drug Targets, V. 10, P. 42-50, 2009.
66. Sugaya, K. Et Al. Three Genes In The Human Mhc Class Iii Region Near The Junction With The Class Ii: Gene For Receptor Of Advanced Glycosylation End Products, Pbx2 Homeobox Gene And A Notch Homolog, Human Counterpart Of Mouse Mammary Tumor Gene Int-3. Genomics, V. 23, P. 408-19, 1994. (Pubitemid 24308262)
67. Tam, X. H. Et Al. Enhanced Expression Of Receptor For Advanced Glycation End-Products Is Associated With Low Circulating Soluble Isoforms Of The Receptor In Type 2 Diabetes. Clin Sci (Lond), V. 120, P. 81-9, 2011.
68. Tesarová, P. Et Al. Receptor For Advanced Glycation End Products (Rage)-Soluble Form (Srage) And Gene Polymorphisms In Patients With Breast Cancer. Cancer Invest, V. 25, P. 720-5, 2007.
69. Tessier, F. J. The Maillard Reaction In The Human Body. The Main Discoveries And Factors That Affect Glycation. Pathol Biol (Paris), V. 58, P. 214-9, 2010.
70. Thomas, M. C. Advanced Glycation End Products. Contrib Nephrol, V. 170, P. 66-74, 2011.
71. Thorpe, S. R.; Baynes, J. W. Maillard Reaction Products In Tissue Proteins: New Products And New Perspectives. Amino Acids, V. 25, P. 275-81, 2003. (Pubitemid 38041265)
72. Wang, E.; Cambi, F. Heterogeneous Nuclear Ribonucleoproteins H And F Regulate The Proteolipid Protein/Dm20 Ratio By Recruiting U1 Small Nuclear Ribonucleoprotein Through A Complex Array Of G Runs. J Biol Chem, V. 284, P.11194-204, 2009.
73. Wautier, J. L. Et Al. Receptor-Mediated Endothelial Cell Dysfunction In Diabetic Vasculopathy. Soluble Receptor For Advanced Glycation End Products Blocks Hyperpermeability In Diabetic Rats. J Clin Invest, V. 97, P. 238-43, 1996.
74. White, J. M. Adams: Modulators Of Cell-Cell And Cell-Matrix Interactions. Curr Opin Cell Biol, V. 15, P. 598-606, 2003. (Pubitemid 37176969)
75. Who. World Health Organization. Diabetes Programme. DisponíVel Em: . Acesso Em: 7 Jan. 2011.
76. Yamagishi, S. I. Et Al. Role Of Advanced Glycation End Products (Ages) And Oxidative Stress In Vascular Complications In Diabetes. Biochim Biophys Acta, V. 1820, P. 663-71, 2012.
77. Yonekura, H. Et Al. Novel Splice Variants Of The Receptor For Advanced Glycation End-Products Expressed In Human Vascular Endothelial Cells And Pericytes, And Their Putative Roles In Diabetes-Induced Vascular Injury. Biochem J, V. 370, P. 1097-109, 2003. (Pubitemid 36399105)
78. Yonekura, H. Et Al. Roles Of The Receptor For Advanced Glycation Endproducts In Diabetes-Induced Vascular Injury. J Pharmacol Sci, V. 97, P. 305-11, 2005. (Pubitemid 40515743)
79. Zeng, S. Et Al. Receptor For Advanced Glycation End Product (Rage)-Dependent Modulation Of Early Growth Response-1 In Hepatic Ischemia/Reperfusion Injury. J Hepatol, V. 50, P. 929-36, 2009.
80. Zhang, L. Et Al. Receptor For Advanced Glycation End Products Is Subjected To Protein Ectodomain Shedding By Metalloproteinases. J Biol Chem, V. 283, P. 35507-16, 2008.
81. Zong, H. Et Al. Homodimerization Is Essential For The Receptor For Advanced Glycation End Products (Rage)-Mediated Signal Transduction. J Biol Chem, V. 285, P. 23137-46, 2010.